Neuronal and Vascular Plasticity Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery

Galen in the 2nd century AD could be considered one of the earliest researchers who attempted to bridge the gap between basic science and clinical medicine. Galen is given initial credit for the recognition that vital organs of the body are exquisitely dependent upon the intact function of the circu...

Full description

Bibliographic Details
Other Authors: Maiese, Kenneth (Editor)
Format: eBook
Language:English
Published: New York, NY Springer US 2003, 2003
Edition:1st ed. 2003
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03313nmm a2200277 u 4500
001 EB000623551
003 EBX01000000000000000476633
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9781461502821 
100 1 |a Maiese, Kenneth  |e [editor] 
245 0 0 |a Neuronal and Vascular Plasticity  |h Elektronische Ressource  |b Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery  |c edited by Kenneth Maiese 
250 |a 1st ed. 2003 
260 |a New York, NY  |b Springer US  |c 2003, 2003 
300 |a XIV, 305 p  |b online resource 
505 0 |a 1 Transformation into Treatment: Novel Therapeutics that Begin Within the Cell -- 2 Cholinergic Plasticity and the Meaning of Death -- 3 Restorative Potential of Angiogenesis After Ischemic Stroke -- 4 Vascular Endothelial Function: Role of Gonadal Steroids -- 5 Alterations of Synaptic Transmission Following Transient Cerebral Ischemia -- 6 The Future of Brain Protection: Natural Alternatives -- 7 Iron S Involvement in the Molecular Mechanisms and Pathogenesis of Alzheimer S Disease -- 8 Ethanol-Induced Neurodegeneration: Basic Mechanisms and Therapeutic Approaches -- 9 Regulation of Neural Stem Cells in the Adult Mammalian Brain -- 10 G-Protein Mediated Metabotropic Receptors Offer Novel Avenues in Neuronal and Vascular Cells for Cytoprotective Strategies 
653 |a Neurosciences 
653 |a Neurosciences 
653 |a Neurology  
653 |a Neurology 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
856 4 0 |u https://doi.org/10.1007/978-1-4615-0282-1?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 612.8 
520 |a Galen in the 2nd century AD could be considered one of the earliest researchers who attempted to bridge the gap between basic science and clinical medicine. Galen is given initial credit for the recognition that vital organs of the body are exquisitely dependent upon the intact function of the circulatory system. The doctrines of Galenic physiology stated that blood was produced in the liver, flowed to the heart to obtain "vital spirits", and subsequently bathed the brain to gain "animal spirits". The "vital spirits" described by Galen were later disclosed to consist of oxygen. Oxygen was discovered independently by Schiele in Sweden and by Priestly in England. It was named oxygen (acid-former) by Antoine Lavoisier (1743-1794) of France. Lavoisier made significant medical discoveries concerning oxygen's role in respiration. In animal experiments, Lavoisier and others discovered that anoxia could rapidly lead to death. The initial work by these investigators helped provide direction for modern clinical science and the treatment of disease, especially concerning disorders of the nervous system. Remarkably, our understanding of human disease continues to grow at an exponential rate. At times, the accumulation of knowledge of the cellular components of clinical disease exceeds all prior expectations held just a few years ago, such as evidenced by the recent cloning of the human and mouse genomes. Despite theses advances, both biomedical scientists and clinicians sometimes are at a loss to recognize the crucial link between basic science discovery and the development of therapeutic regiments for clinical disease